<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">576</article-id><article-id pub-id-type="doi">10.24287/j.576</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>РЕЗОЛЮЦИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="ru">Резолюция Совета экспертов</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Редакционная</surname><given-names>статья</given-names></name><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution></institution></aff><pub-date date-type="pub" iso-8601-date="2021-12-22" publication-format="electronic"><day>22</day><month>12</month><year>2021</year></pub-date><volume>20</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>214</fpage><lpage>217</lpage><history><date date-type="received" iso-8601-date="2021-12-22"><day>22</day><month>12</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-12-22"><day>22</day><month>12</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/576">https://hemoncim.com/jour/article/view/576</self-uri><abstract xml:lang="ru"><p>15 мая 2021 г. в Санкт-Петербурге состоялось экспертное совещание по вопросам расширения возможностей терапии гемофилии А и места рекомбинантного одноцепочечного фактора VIII (лоноктоког альфа) в рутинной клинической практике.</p></abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Воробьев П.А., Краснова Л.С., Воробьев А.П., Зыкова А.Б., Жулев Ю.А., Зозуля Н.И. Эпидемиология, экономика и качество жизни больных гемофилией в России в 2007–2017 гг.: результаты применения стандартизации в терапии. Проблемы стандартизации в здравоохранении 2018; 9–10: 15–34.</mixed-citation><mixed-citation xml:lang="ru">Воробьев П.А., Краснова Л.С., Воробьев А.П., Зыкова А.Б., Жулев Ю.А., Зозуля Н.И. Эпидемиология, экономика и качество жизни больных гемофилией в России в 2007–2017 гг.: результаты применения стандартизации в терапии. Проблемы стандартизации в здравоохранении 2018; 9–10: 15–34.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Исследование состояния удовлетворенности лечения взрослых пациентов с гемофилией А в России. Опрос компании IQVIA при поддержке компании CSL Behring, 2021.</mixed-citation><mixed-citation xml:lang="ru">Исследование состояния удовлетворенности лечения взрослых пациентов с гемофилией А в России. Опрос компании IQVIA при поддержке компании CSL Behring, 2021.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Рубрикатор клинических рекомендаций. Клинические рекомендации. Гемофилия. ID: 127. 2018. [Электронный ресурс] URL: https://cr.minzdrav.gov.ru/schema/127_1 (дата обращения: 09.08.2021).</mixed-citation><mixed-citation xml:lang="ru">Рубрикатор клинических рекомендаций. Клинические рекомендации. Гемофилия. ID: 127. 2018. [Электронный ресурс] URL: https://cr.minzdrav.gov.ru/schema/127_1 (дата обращения: 09.08.2021).</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Srivastava A., Santagostino E., Dougall A., Kitchen S., Sutherland M., Pipe S.W., et al on behalf of the WFH Guidelines for the Management of Hemophilia panelists and co-authors. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia 2020; 26 (Suppl 6): 1–158.</mixed-citation><mixed-citation xml:lang="ru">Srivastava A., Santagostino E., Dougall A., Kitchen S., Sutherland M., Pipe S.W., et al on behalf of the WFH Guidelines for the Management of Hemophilia panelists and co-authors. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia 2020; 26 (Suppl 6): 1–158.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Инструкция по медицинскому применению лекарственного препарата АФСТИЛА, ЛП-006975, 26.04.2021.</mixed-citation><mixed-citation xml:lang="ru">Инструкция по медицинскому применению лекарственного препарата АФСТИЛА, ЛП-006975, 26.04.2021.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Klamroth R., Simpson M., von Depka-Prondzinski M., Gill J.C., Morfini M., Powell J.S., et al. Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate) in patients with severe haemophilia A. Haemophilia 2016, 22: 730–8.</mixed-citation><mixed-citation xml:lang="ru">Klamroth R., Simpson M., von Depka-Prondzinski M., Gill J.C., Morfini M., Powell J.S., et al. Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate) in patients with severe haemophilia A. Haemophilia 2016, 22: 730–8.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Mahlangu J., Kuliczkowski K., Karim F., Stasyshyn O., Kosinova M.V., Mae Lepatan L., et al. Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A. Blood 2016; 128 (5): 630–7.</mixed-citation><mixed-citation xml:lang="ru">Mahlangu J., Kuliczkowski K., Karim F., Stasyshyn O., Kosinova M.V., Mae Lepatan L., et al. Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A. Blood 2016; 128 (5): 630–7.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Stasyshyn O., Djambas K., Iosava G., Ong J., Abdul Karim F., Fischer K., et al. Safety, efficacy and pharmacokinetics of rVIII-SingleChain in children with severe hemophilia A: results of a multicenter clinical trial. J Thromb Haemost 2017; 15 (4): 636–44.</mixed-citation><mixed-citation xml:lang="ru">Stasyshyn O., Djambas K., Iosava G., Ong J., Abdul Karim F., Fischer K., et al. Safety, efficacy and pharmacokinetics of rVIII-SingleChain in children with severe hemophilia A: results of a multicenter clinical trial. J Thromb Haemost 2017; 15 (4): 636–44.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Oliviery M., Sommerer P., Maroet G. Yan S. Assessing prophylactic use and clinical outcomes in hemophilia A patients treated with rVIII-Single Chain and other common rFVIII products in Germany. Eur J Haematol 2020; 104: 310–7.</mixed-citation><mixed-citation xml:lang="ru">Oliviery M., Sommerer P., Maroet G. Yan S. Assessing prophylactic use and clinical outcomes in hemophilia A patients treated with rVIII-Single Chain and other common rFVIII products in Germany. Eur J Haematol 2020; 104: 310–7.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
